Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michaela J Higgins

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Nature Reviews. Clinical Oncology|February 1, 2011
Breast cancer in 2010: Novel targets and therapies for a personalized approachMichaela J Higgins, José Baselga
Best Practice & Research. Clinical Haematology|July 20, 2005
Genetics of multiple myelomaMichaela J Higgins, Rafael Fonseca
Current Oncology Reports|April 29, 2010
CYP2D6 polymorphisms and tamoxifen metabolism: clinical relevanceMichaela J Higgins, Vered Stearns
Annual Review of Medicine|January 14, 2011
Pharmacogenetics of endocrine therapy for breast cancerMichaela J Higgins, Vered Stearns
Clinical Chemistry|June 23, 2009
Understanding resistance to tamoxifen in hormone receptor-positive breast cancerMichaela J Higgins, Vered Stearns
The Oncologist|May 19, 2011
All nodes lead to chemoLidia Schapira, Michaela J Higgins
The Journal of Clinical Investigation|October 4, 2011
Targeted therapies for breast cancerMichaela J Higgins, José Baselga
Expert Review of Anticancer Therapy|August 13, 2009
Expanding role of bisphosphonates in the management of early breast cancerMichaela J Higgins, Ben H Park
Current Oncology Reports|December 17, 2008
What is the current status of ovarian suppression/ablation in women with premenopausal early-stage breast cancer?Michaela J Higgins, Nancy E Davidson
Oncology (Williston Park, N.Y.)|March 17, 2009
Adjuvant endocrine therapy for premenopausal hormone receptor-positive breast cancer; much done, more to doMichaela J Higgins, Antonio C Wolf
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Nature Reviews. Clinical Oncology|February 1, 2011
Breast cancer in 2010: Novel targets and therapies for a personalized approachMichaela J Higgins, José Baselga
Best Practice & Research. Clinical Haematology|July 20, 2005
Genetics of multiple myelomaMichaela J Higgins, Rafael Fonseca
Current Oncology Reports|April 29, 2010
CYP2D6 polymorphisms and tamoxifen metabolism: clinical relevanceMichaela J Higgins, Vered Stearns
Annual Review of Medicine|January 14, 2011
Pharmacogenetics of endocrine therapy for breast cancerMichaela J Higgins, Vered Stearns
Clinical Chemistry|June 23, 2009
Understanding resistance to tamoxifen in hormone receptor-positive breast cancerMichaela J Higgins, Vered Stearns
The Oncologist|May 19, 2011
All nodes lead to chemoLidia Schapira, Michaela J Higgins
The Journal of Clinical Investigation|October 4, 2011
Targeted therapies for breast cancerMichaela J Higgins, José Baselga
Expert Review of Anticancer Therapy|August 13, 2009
Expanding role of bisphosphonates in the management of early breast cancerMichaela J Higgins, Ben H Park
Current Oncology Reports|December 17, 2008
What is the current status of ovarian suppression/ablation in women with premenopausal early-stage breast cancer?Michaela J Higgins, Nancy E Davidson
Oncology (Williston Park, N.Y.)|March 17, 2009
Adjuvant endocrine therapy for premenopausal hormone receptor-positive breast cancer; much done, more to doMichaela J Higgins, Antonio C Wolf
Pageof 5